Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma (original) (raw)

serum YKL-40 Levels in patients with esophageal

Ozgur Kemik

2011

View PDFchevron_right

Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinimo

Ahmet Cumhur Dülger

Cancer Growth and Metastasis, 2011

View PDFchevron_right

Serum YKL-40 Levels in Patients with Gastric Cancer

Ozgur Kemik

Biomarkers in Cancer, 2011

View PDFchevron_right

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival

Katalin Kiss, Eva Balslev

International Journal of Cancer, 2008

View PDFchevron_right

Utility of serum YKL-40 as a tumor-specific marker of hepatobiliary malignancies

Surakit Pungpapong

2010

View PDFchevron_right

High serum YKL-40 level is associated with poor prognosis in patients with lung cancer

İsmail Savaş

Tuberkuloz ve Toraks

View PDFchevron_right

Assessment of importance of YKL-40 protein as biomarker in colorectal cancer and its relation to selected clinical and pathological parameters

Zbigniew Lorenc

Annales Academiae Medicae Silesiensis, 2021

View PDFchevron_right

Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?

Benny Jensen

Cancer Epidemiology Biomarkers & Prevention, 2006

View PDFchevron_right

High serum YKL-40 level in patients with small cell lung cancer is related to early death

Julia Johansen

Lung Cancer, 2004

View PDFchevron_right

Overexpression of YKL-40 is an independent prognostic marker in gastric cancer

Xin-yuan Guan

Human Pathology, 2009

View PDFchevron_right

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

Banu çaycı

Advances in Therapy, 2008

View PDFchevron_right

Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells

Peter Nørgaard

European Journal of Haematology, 2006

View PDFchevron_right

Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer

Lars Jørgensen

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015

View PDFchevron_right

Elevated Serum YKL-40 Level Predicts Poor Prognosis in Hepatocellular Carcinoma After Surgery

Jian Tian

Annals of Surgical Oncology, 2012

View PDFchevron_right

The place of YKL-40 in non-small cell lung cancer

Ayşegül Güneş

Tüberküloz ve toraks, 2014

View PDFchevron_right

Role of YKL-40 in cutaneous and systemic diseases

yomna mazid

International Journal of Dermatology, Venereology and Leprosy Sciences

View PDFchevron_right

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival

Julia Johansen

Oncology Reports, 2003

View PDFchevron_right

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis

Jihjong Lee

Journal of Veterinary Science

View PDFchevron_right

The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis

Beata Kotowicz

Technology in Cancer Research & Treatment

View PDFchevron_right

Impact of serum biomarkers on esophageal squamous cell carcinoma

Kazuyuki Matsushita, Takaki Hiwasa

2012

View PDFchevron_right

YKL-40 – a New Diagnostic Biomarcer for Benign Breast Diseases and Breast Cancer

K. Murdjev, Albena Paskaleva

Journal of IMAB - Annual Proceeding (Scientific Papers), 2010

View PDFchevron_right

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

Richard B Arenas MD

Oncogene, 2009

View PDFchevron_right

YKL-40 - a New Diagnostic Biomarker for Benign Breast Diseases and Breast Cancer

V. Sarafian

2010

View PDFchevron_right

Expression of YKL-40, an Inflammatory Glycoprotein and its Prognostic Implications in Cancer

Saksham yadav

Journal of Molecular Biomarkers & Diagnosis, 2012

View PDFchevron_right

Prognostic effect of serum and tissue YKL-40 levels in bladder cancer

Péter Nyirády

Urologic Oncology: Seminars and Original Investigations, 2014

View PDFchevron_right

YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis

Angelo Casalini

Anticancer research, 2013

View PDFchevron_right

Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40

Sibyl Anderson

Journal of Clinical Oncology, 2004

View PDFchevron_right

Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

Jian Tian

PLoS ONE, 2012

View PDFchevron_right

High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker

Tiina Luukkaala

Scandinavian journal of urology, 2017

View PDFchevron_right

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

Richard B Arenas MD

Breast Diseases: A Year Book Quarterly, 2012

View PDFchevron_right

Clinical Significance of Serum YKL-40 and its Correlation with Serum IL6 and CRP in Breast Cancer Patients

Enas A Elkhouly

Research in Oncology, 2014

View PDFchevron_right

Tumor Markers in Serum of Patients with Primary Squamous Cell Carcinoma of the Esophagus

Ruggero Dittadi

Tumori Journal, 1989

View PDFchevron_right

Tumor Markers in Squamous Cell Carcinoma of Esophagus: Immunometric Assay in Cytosol and Membrane Fraction

Ruggero Dittadi

The International Journal of Biological Markers, 1990

View PDFchevron_right